Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-011305
Filing Date
2025-08-13
Accepted
2025-08-13 07:41:02
Documents
116
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xoma-20250630x10q.htm   iXBRL 10-Q 3219430
2 EX-3.2 xoma-20250630xex3d2.htm EX-3.2 77007
3 EX-3.3 xoma-20250630xex3d3.htm EX-3.3 93822
4 EX-3.4 xoma-20250630xex3d4.htm EX-3.4 87645
5 EX-10.2 xoma-20250630xex10d2.htm EX-10.2 70468
6 EX-31.1 xoma-20250630xex31d1.htm EX-31.1 13988
7 EX-31.2 xoma-20250630xex31d2.htm EX-31.2 14008
8 EX-32.1 xoma-20250630xex32d1.htm EX-32.1 8590
  Complete submission text file 0001558370-25-011305.txt   15371214

Data Files

Seq Description Document Type Size
9 EX-101.SCH xoma-20250630.xsd EX-101.SCH 111550
10 EX-101.CAL xoma-20250630_cal.xml EX-101.CAL 93785
11 EX-101.DEF xoma-20250630_def.xml EX-101.DEF 546865
12 EX-101.LAB xoma-20250630_lab.xml EX-101.LAB 844319
13 EX-101.PRE xoma-20250630_pre.xml EX-101.PRE 773828
119 EXTRACTED XBRL INSTANCE DOCUMENT xoma-20250630x10q_htm.xml XML 2886498
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Royalty Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 251209012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)